Info

Anergen, Inc. (Nasdaq: ANRG) is a biotechnology company focused on advancing the treatment of autoimmune diseases. The Company is developing proprietary biopharmaceutical compounds designed to selectively interrupt antigen presentation or inactivate those T cells that mediate the disease process.